We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
(+28%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$1.47B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
Walt Disney
DIS
|
+$896M |
| 4 |
Salesforce
CRM
|
+$633M |
| 5 |
Intuitive Surgical
ISRG
|
+$407M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$751M |
| 2 |
Procter & Gamble
PG
|
+$623M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$579M |
| 4 |
Merck
MRK
|
+$440M |
| 5 |
Yum China
YUMC
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Healthcare | 12.96% |
| 4 | Communication Services | 12.75% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Johnson & Johnson
JNJ
$629B
| $2.13M | ﹤0.01% |
15,116
-916
| -6% | -$133K |
|
|
402
Procter & Gamble
PG
$340B
| $2.11M | ﹤0.01% |
17,636
-5,345,667
| -100% | -$623M |
|
403
GDS Holdings
GDS
$6.26B
| $1.95M | ﹤0.01% |
24,495
+1,377
| +6% | +$85.2K |
|
|
VNET
404
VNET Group
VNET
$2.09B
| $1.92M | ﹤0.01% |
80,382
+34,773
| +76% | +$561K |
|
405
Booking.com
BKNG
$158B
| $1.81M | ﹤0.01% |
28,400
-250
| -0.9% | -$15.2K |
|
406
iShares Core S&P 500 ETF
IVV
$904B
| $1.7M | ﹤0.01% |
5,500
| – | – |
|
407
Walmart Inc
WMT
$890B
| $1.65M | ﹤0.01% |
41,310
+10,812
| +35% | +$445K |
|
408
IBM
IBM
$222B
| $1.63M | ﹤0.01% |
14,077
-48
| -0.3% | -$5.58K |
|
|
409
Amgen
AMGN
$224B
| $1.52M | ﹤0.01% |
6,441
-3,290,789
| -100% | -$751M |
|
410
Duke Energy
DUK
$95.3B
| $1.42M | ﹤0.01% |
17,806
+8
| +0% | +$676 |
|
411
Dominion Energy
D
$59.1B
| $1.41M | ﹤0.01% |
17,413
-9,019
| -34% | -$723K |
|
412
Core Laboratories
CLB
$542M
| $1.37M | ﹤0.01% |
67,530
+16,912
| +33% | +$303K |
|
413
Lam Research
LRCX
$385B
| $1.28M | ﹤0.01% |
39,700
-2,170
| -5% | -$59.2K |
|
|
NBIS
414
Nebius Group N.V.
NBIS
$47.7B
| $1.25M | ﹤0.01% |
24,989
| – | – |
|
415
Broadcom
AVGO
$2.01T
| $1.17M | ﹤0.01% |
37,190
-3,410
| -8% | -$95.4K |
|
416
Eli Lilly
LLY
$1.08T
| $1.17M | ﹤0.01% |
7,103
-851
| -11% | -$131K |
|
417
Dollar General
DG
$27.3B
| $1.16M | ﹤0.01% |
6,065
+5,281
| +674% | +$956K |
|
418
Cencora
COR
$61.8B
| $1.15M | ﹤0.01% |
11,398
-1,690
| -13% | -$156K |
|
419
Applied Materials
AMAT
$420B
| $1.14M | ﹤0.01% |
18,826
-637
| -3% | -$34.4K |
|
420
AbbVie
ABBV
$435B
| $1.14M | ﹤0.01% |
11,559
-2,446
| -17% | -$215K |
|
421
Intel
INTC
$501B
| $1.13M | ﹤0.01% |
18,902
-2,099
| -10% | -$126K |
|
422
Comcast
CMCSA
$88.9B
| $1.12M | ﹤0.01% |
28,785
-1,031
| -3% | -$39.3K |
|
423
HP
HPQ
$27.6B
| $1.12M | ﹤0.01% |
64,014
+6,241
| +11% | +$99.2K |
|
|
424
Merck
MRK
$323B
| $1.11M | ﹤0.01% |
15,112
-5,839,501
| -100% | -$440M |
|
425
Domino's
DPZ
$11.4B
| $1.1M | ﹤0.01% |
2,991
-182
| -6% | -$67.1K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.
- Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
- Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
- Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
- Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
- Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
- Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
- Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.